Article

Debulking procedures not beneficial in patients with end-stage prostate cancer

Primary therapy for prostate cancer does not reduce the frequency of end-of-life urologic procedures, according to the findings of a population-based study.

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
William Furuyama, MD, answers a question during a Zoom video interview
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.